Related Experiment Video
Updated: Apr 26, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy
Wei Sun1, Chwee Teck Lim2, Nicholas Agung Kurniawan3
1NUS Graduate School for Integrative Sciences and Engineering, Singapore 117456, Republic of Singapore.
Abstract:
Cancer metastasis involves the dissemination of cancer cells from the primary tumour site and is responsible for the majority of solid tumour-related mortality. Screening of anti-metastasis drugs often includes functional assays that examine cancer cell invasion inside a three-dimensional hydrogel that mimics the extracellular matrix (ECM). Here, we built a mechanically tuneable collagen hydrogel model to recapitulate cancer spreading into heterogeneous tumour stroma and monitored the three-dimensional invasion of highly malignant breast cancer cells, MDA-MB-231. Migration assays were carried out in the presence and the absence of drugs affecting four typical molecular mechanisms involved in cell migration, as well as under five ECMs with different biophysical properties. Strikingly, the effects of the drugs were observed to vary strongly with matrix mechanics and microarchitecture, despite the little dependence of the inherent cancer cell migration on the ECM condition. Specifically, cytoskeletal contractility-targeting drugs reduced migration speed in sparse gels, whereas migration in dense gels was retarded effectively by inhibiting proteolysis. The results corroborate the ability of cancer cells to switch their multiple invasion mechanisms depending on ECM condition, thus suggesting the importance of factoring in the biophysical properties of the ECM in anti-metastasis drug screenings.
Insights
Drug effectiveness against cancer metastasis varies with the extracellular matrix (ECM) environment. Targeting cytoskeletal contractility works in sparse gels, while inhibiting proteolysis is key in dense gels for anti-metastasis drug screening.
Area of Science:
- Biomedical Engineering
- Cancer Biology
- Materials Science
Background:
- Cancer metastasis is a major cause of cancer mortality.
- Drug screening for anti-metastasis therapies often uses 3D hydrogel models mimicking the extracellular matrix (ECM).
- Understanding how cancer cells invade through the ECM is crucial for developing effective treatments.
Purpose of the Study:
- To develop a mechanically tuneable collagen hydrogel model to simulate cancer cell invasion into heterogeneous tumor stroma.
- To investigate the impact of ECM biophysical properties on cancer cell migration and drug efficacy.
- To assess how different anti-metastasis drugs perform under varying matrix conditions.
Main Methods:
- Fabrication of a mechanically tuneable collagen hydrogel system.
- Monitoring 3D invasion of highly malignant breast cancer cells (MDA-MB-231).
- Conducting migration assays with drugs targeting cell migration mechanisms across diverse ECMs with varied biophysical properties.
Main Results:
- Drug effects on cancer cell migration were highly dependent on matrix mechanics and microarchitecture.
- Cytoskeletal contractility inhibitors reduced migration in sparse gels.
- Proteolysis inhibitors were effective in retarding migration in dense gels.
- Cancer cells demonstrated adaptability in switching invasion mechanisms based on ECM conditions.
Conclusions:
- The efficacy of anti-metastasis drugs is significantly influenced by the biophysical properties of the tumor microenvironment.
- Cancer cells exhibit plasticity in their invasion strategies, adapting to different ECM conditions.
- Incorporating ECM biophysical properties into anti-metastasis drug screening is essential for developing effective therapies.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Treatment Resistant Cancers
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...

